AAAAAA

   
Results: 1-25 | 26-34
Results: 1-25/34
ABOUT THE DETERMINATION OF CRITICAL EXPONENTS RELATED TO POSSIBLE PHASE-TRANSITIONS IN NUCLEAR FRAGMENTATION
Authors: ELATTARI B RICHERT J WAGNER P
Citation: B. Elattari et al., ABOUT THE DETERMINATION OF CRITICAL EXPONENTS RELATED TO POSSIBLE PHASE-TRANSITIONS IN NUCLEAR FRAGMENTATION, Journal of physics. G, Nuclear and particle physics, 24(3), 1998, pp. 601-609
A MODEL FOR NUCLEAR-MATTER FRAGMENTATION - PHASE-DIAGRAM AND CLUSTER DISTRIBUTIONS
Authors: CARMONA J RICHERT J TARANCON A
Citation: J. Carmona et al., A MODEL FOR NUCLEAR-MATTER FRAGMENTATION - PHASE-DIAGRAM AND CLUSTER DISTRIBUTIONS, Nuclear physics. A, 643(2), 1998, pp. 115-134
THERMODYNAMICS OF A FINITE SYSTEM OF CLASSICAL PARTICLES WITH SHORT-RANGE AND LONG-RANGE INTERACTIONS AND NUCLEAR FRAGMENTATION
Authors: RICHERT J WAGNER P HENKEL M CARMONA JM
Citation: J. Richert et al., THERMODYNAMICS OF A FINITE SYSTEM OF CLASSICAL PARTICLES WITH SHORT-RANGE AND LONG-RANGE INTERACTIONS AND NUCLEAR FRAGMENTATION, Nuclear physics. A, 639(3-4), 1998, pp. 717-730
NEUROPSYCHOLOGICAL EFFECTS OF AVONEX(R) (INTERFERON-BETA-1A) IN RELAPSING MULTIPLE-SCLEROSIS (MS)
Authors: FISCHER JS PRIORE R JACOBS L COOKFAIR D RUDICK R HERNDON R RICHERT J SALAZAR A GOODKIN D GRANGER C SIMON J GRAFMAN J LEZAK M OREILLY K SCHACTER M SHUCARD D DAVIDSON A WENDE K
Citation: Js. Fischer et al., NEUROPSYCHOLOGICAL EFFECTS OF AVONEX(R) (INTERFERON-BETA-1A) IN RELAPSING MULTIPLE-SCLEROSIS (MS), Neurology, 50(4), 1998, pp. 1070-1070
CSF KAPPA-LIGHT-CHAINS AND GADOLINIUM-ENHANCING BRAIN-LESIONS AS PREDICTORS OF RESPONSE TO THERAPY WITH INTERFERON-BETA 1A (AVONEX(R)) IN PATIENTS WITH RELAPSING MULTIPLE-SCLEROSIS
Authors: RUDICK R COOKFAIR D SIMON J SIMONIAN N JACOBS L HERNDON R RICHERT J SALAZAR A FISCHER J GRANGER C GOODKIN D OREILLY K BOYLE S
Citation: R. Rudick et al., CSF KAPPA-LIGHT-CHAINS AND GADOLINIUM-ENHANCING BRAIN-LESIONS AS PREDICTORS OF RESPONSE TO THERAPY WITH INTERFERON-BETA 1A (AVONEX(R)) IN PATIENTS WITH RELAPSING MULTIPLE-SCLEROSIS, Neurology, 50(4), 1998, pp. 47001-47001
PHASE-SPACE CHARACTERISTICS OF FRAGMENTING NUCLEI DESCRIBED AS EXCITED DISORDERED-SYSTEMS
Authors: RICHERT J BOOSE D LEJEUNE A WAGNER P
Citation: J. Richert et al., PHASE-SPACE CHARACTERISTICS OF FRAGMENTING NUCLEI DESCRIBED AS EXCITED DISORDERED-SYSTEMS, Nuclear physics. A, 615(1), 1997, pp. 1-17
ONGOING EFFICACY AND SAFETY ANALYSIS OF INTERFERON-BETA-1A (AVONEX) IN PATIENTS WITH MULTIPLE-SCLEROSIS
Authors: HERNDON RM COATS M GOODKIN D MASS M RICHERT J RUDICK RA WEINSTOCKGUTTMAN B SIMONIAN NA CAMPION M SCARAMOCCI J ALAM JJ JACOBS LD
Citation: Rm. Herndon et al., ONGOING EFFICACY AND SAFETY ANALYSIS OF INTERFERON-BETA-1A (AVONEX) IN PATIENTS WITH MULTIPLE-SCLEROSIS, Annals of neurology, 42(6), 1997, pp. 6-6
BIOLOGICAL-ACTIVITY OF INTERLEUKIN-10 IN THE CENTRAL-NERVOUS-SYSTEM
Authors: ZOCCHIA C SPIGA G RABIN SJ GREKOVA M RICHERT J CHERNYSHEV O COLTON C MOCCHETTI I
Citation: C. Zocchia et al., BIOLOGICAL-ACTIVITY OF INTERLEUKIN-10 IN THE CENTRAL-NERVOUS-SYSTEM, Neurochemistry international, 30(4-5), 1997, pp. 433-439
SPECSOLV - AN INNOVATION AT WORK
Authors: WILL M RICHERT J
Citation: M. Will et J. Richert, SPECSOLV - AN INNOVATION AT WORK, Journal of chemical information and computer sciences, 37(2), 1997, pp. 403-404
CONTROL-STRUCTURES FOR VEHICLE CONVOY CONTROL
Authors: SEUSS J RICHERT J
Citation: J. Seuss et J. Richert, CONTROL-STRUCTURES FOR VEHICLE CONVOY CONTROL, Vehicle System Dynamics, 28(6), 1997, pp. 339-356
FATIGUE SEVERITY IN LOW DISABILITY MS PATIENTS PARTICIPATING IN A PHASE-III TRIAL OF AVONEX(TM) (IFN-BETA-1A) FOR RELAPSING MULTIPLE-SCLEROSIS
Authors: COOKFAIR DL FISCHER J RUDICK R JACOBS L HERNDON R RICHERT J SALAZAR A GRANGER C SIMON J GOODKIN D
Citation: Dl. Cookfair et al., FATIGUE SEVERITY IN LOW DISABILITY MS PATIENTS PARTICIPATING IN A PHASE-III TRIAL OF AVONEX(TM) (IFN-BETA-1A) FOR RELAPSING MULTIPLE-SCLEROSIS, Neurology, 48(3), 1997, pp. 3066-3066
SIGNIFICANCE OF SERUM NEUTRALIZING ANTIBODIES TO AVONEX' (IFN-BETA-1A) IN MULTIPLE-SCLEROSIS
Authors: RUDICK RA JONES W ALAM J SIMONIAN N CAMPION M JACOBS L HERNDON R RICHERT J SALAZAR A COOKFAIR D SIMON J COATS M GOODKIN D MASS M
Citation: Ra. Rudick et al., SIGNIFICANCE OF SERUM NEUTRALIZING ANTIBODIES TO AVONEX' (IFN-BETA-1A) IN MULTIPLE-SCLEROSIS, Neurology, 48(3), 1997, pp. 5003-5003
UNIVERSAL PROPERTY OF MULTIFRAGMENTATION IN NUCLEUS-NUCLEUS COLLISIONS
Authors: ZHENG YM RICHERT J WAGNER P
Citation: Ym. Zheng et al., UNIVERSAL PROPERTY OF MULTIFRAGMENTATION IN NUCLEUS-NUCLEUS COLLISIONS, Journal of physics. G, Nuclear and particle physics, 22(4), 1996, pp. 505-510
PHENOMENOLOGICAL MODEL OF FISSION-BARRIERS OF HOT ROTATING NUCLEI
Authors: BARTEL J MAHBOUB K RICHERT J POMORSKI K
Citation: J. Bartel et al., PHENOMENOLOGICAL MODEL OF FISSION-BARRIERS OF HOT ROTATING NUCLEI, ZEITSCHRIFT FUR PHYSIK A-HADRONS AND NUCLEI, 354(1), 1996, pp. 59-65
EVAPORATION OF LIGHT PARTICLES FROM A HOT, DEFORMED AND ROTATING NUCLEUS
Authors: POMORSKI K BARTEL J RICHERT J DIETRICH K
Citation: K. Pomorski et al., EVAPORATION OF LIGHT PARTICLES FROM A HOT, DEFORMED AND ROTATING NUCLEUS, Nuclear physics. A, 605(1), 1996, pp. 87-119
CEREBROSPINAL-FLUID ABNORMALITIES IN A PHASE-III TRIAL INTERFERON BETA-1A (AVONEX) FOR RELAPSING MULTIPLE-SCLEROSIS
Authors: RUDICK RA COOKFAIR RD RANSOHOFF R JACOBS L HERNDON R RICHERT J SALAZAR A FISCHER J GRANGER C SIMON J GOODKIN D
Citation: Ra. Rudick et al., CEREBROSPINAL-FLUID ABNORMALITIES IN A PHASE-III TRIAL INTERFERON BETA-1A (AVONEX) FOR RELAPSING MULTIPLE-SCLEROSIS, Annals of neurology, 40(3), 1996, pp. 104-104
QUALITY-OF-LIFE IN LOW-DISABILITY MULTIPLE-SCLEROSIS PATIENTS PARTICIPATING IN A PHASE-III TRIAL OF INTERFERON BETA-1A FOR RELAPSING MULTIPLE-SCLEROSIS
Authors: COOKFAIR DL FISCHER J RUDICK R BOURDETTE D OREILLY K JACOBS L HERNDON R RICHERT J SALAZAR A GRANGER C SIMON J GOODKIN D
Citation: Dl. Cookfair et al., QUALITY-OF-LIFE IN LOW-DISABILITY MULTIPLE-SCLEROSIS PATIENTS PARTICIPATING IN A PHASE-III TRIAL OF INTERFERON BETA-1A FOR RELAPSING MULTIPLE-SCLEROSIS, Annals of neurology, 40(3), 1996, pp. 234-234
INTERFERON BETA-1A (AVONEX) INCREASES CEREBROSPINAL-FLUID INTERLEUKIN-10 IN PATIENTS WITH RELAPSING MULTIPLE-SCLEROSIS
Authors: RUDICK RA RANSOHOFF R MEDENDORP S BOYLE S PEPPLER R JACOBS L COCKFAIR D HERNDON R RICHERT J SALAZAR A FISCHER J GRANGER C SIMON J GOODKIN D WENDE K
Citation: Ra. Rudick et al., INTERFERON BETA-1A (AVONEX) INCREASES CEREBROSPINAL-FLUID INTERLEUKIN-10 IN PATIENTS WITH RELAPSING MULTIPLE-SCLEROSIS, Annals of neurology, 40(3), 1996, pp. 244-244
A REVERSE TRANSCRIPTASE-POLYMERASE CHAIN-REACTION ASSAY FOR GENE-EXPRESSION STUDIES AT THE SINGLE-CELL LEVEL
Authors: RICHERT J KRANZ E LORZ H DRESSELHAUS T
Citation: J. Richert et al., A REVERSE TRANSCRIPTASE-POLYMERASE CHAIN-REACTION ASSAY FOR GENE-EXPRESSION STUDIES AT THE SINGLE-CELL LEVEL, PLANT SCI, 114(1), 1996, pp. 93-99
PARTICLE-EMISSION FROM A HOT, DEFORMED, AND ROTATING NUCLEUS
Authors: DIETRICH K POMORSKI K RICHERT J
Citation: K. Dietrich et al., PARTICLE-EMISSION FROM A HOT, DEFORMED, AND ROTATING NUCLEUS, ZEITSCHRIFT FUR PHYSIK A-HADRONS AND NUCLEI, 351(4), 1995, pp. 397-404
CRITICAL PEPTIDE ANCHOR RESIDUES DIFFER FOR DIFFERENT PEPTIDES THAT BIND TO AN INDIVIDUAL HLA-DR MOLECULE AND FOR AN INDIVIDUAL PEPTIDE THAT BINDS TO SEVERAL HLA-DR MOLECULES
Authors: HURLEY CK HASTINGS AE JOHNSON AH RICHERT J POSCH PE
Citation: Ck. Hurley et al., CRITICAL PEPTIDE ANCHOR RESIDUES DIFFER FOR DIFFERENT PEPTIDES THAT BIND TO AN INDIVIDUAL HLA-DR MOLECULE AND FOR AN INDIVIDUAL PEPTIDE THAT BINDS TO SEVERAL HLA-DR MOLECULES, The FASEB journal, 9(4), 1995, pp. 1059-1059
CLUSTER FORMATION IN DISORDERED-SYSTEMS AND NUCLEAR FRAGMENTATION
Authors: ELATTARI B RICHERT J WAGNER P ZHENG YM
Citation: B. Elattari et al., CLUSTER FORMATION IN DISORDERED-SYSTEMS AND NUCLEAR FRAGMENTATION, Nuclear physics. A, 592(3), 1995, pp. 385-412
DISORDER AND UNIVERSALITY PROPERTIES OF FRAGMENTING NUCLEI
Authors: ELATTARI B RICHERT J WAGNER P ZHENG YM
Citation: B. Elattari et al., DISORDER AND UNIVERSALITY PROPERTIES OF FRAGMENTING NUCLEI, Physics letters. Section B, 356(2-3), 1995, pp. 181-185
TOXICITY OF RECOMBINANT INTRAMUSCULAR RECOMBINANT INTERFERON-BETA-1A IN MULTIPLE-SCLEROSIS PATIENTS
Authors: RUDICK RA JACOBS L ALAM J COOKFAIR D HERNDON R RICHERT J SALAZAR A FISCHER J GOODKIN D GRANGER C SIMON J
Citation: Ra. Rudick et al., TOXICITY OF RECOMBINANT INTRAMUSCULAR RECOMBINANT INTERFERON-BETA-1A IN MULTIPLE-SCLEROSIS PATIENTS, Annals of neurology, 38(2), 1995, pp. 313-313
CAMEL - AN OPEN CACSD ENVIRONMENT
Authors: RUTZ R RICHERT J
Citation: R. Rutz et J. Richert, CAMEL - AN OPEN CACSD ENVIRONMENT, Control systems magazine, 15(2), 1995, pp. 26-33
Risultati: 1-25 | 26-34